Accelerating Medicines Partnership
®
Schizophrenia (AMP
®
SCZ): developing tools to enable early intervention in the psychosis high risk state
World Psychiatry
.
2023 Feb;22(1):42-43.
doi: 10.1002/wps.21038.
Authors
Linda S Brady
1
,
Carlos A Larrauri
2
;
AMP SCZ Steering Committee
Affiliations
1
National Institute of Mental Health, Bethesda, MD, USA.
2
National Alliance on Mental Illness, Arlington, VA, USA.
PMID:
36640393
PMCID:
PMC9840500
DOI:
10.1002/wps.21038
No abstract available
Grants and funding
U24 MH124629/MH/NIMH NIH HHS/United States